1. Robert J. Cotter (1943–2012): From Mass Spectrometer Development to the Exploration of Life

   • Lerna Uzasci
   • Avindra Nath

   Commentary 15 June 2013 Pages: 1049 - 1050

   

2. More Than Two HANDs to Tango

   • Dennis Kolson
   • Shilpa Buch

   COMMENTARY Open access 15 November 2013 Pages: 1051 - 1054

3. Biomarkers for NeuroAIDS: Recent Progress in the Field

   • Howard S. Fox

   COMMENTARY 29 November 2013 Pages: 1055 - 1058

   

4. Recurrent Varicella following Steroids and Fingolimod in a Multiple Sclerosis Patient

   • D. Ferraro
   • S. De Biasi
   • P. Sola

   LETTER TO THE EDITOR 27 October 2013 Pages: 1059 - 1061

   

5. Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System

   • Alice Laroni
   • Giovanni Novi
   • Antonio Uccelli

   PERSPECTIVE 12 April 2013 Pages: 1062 - 1076

   

6. Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives

   • Anna Maria Malfitano
   • Chiara Laezza
   • Maurizio Bifulco

   PERSPECTIVE 01 October 2013 Pages: 1077 - 1086

   

7. Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection

   • Edana Cassol
   • Vikas Misra
   • Dana Gabuzda

   PERSPECTIVE Open access 21 November 2013 Pages: 1087 - 1097

   

8. Riluzole Partially Rescues Age-Associated, but not LPS-Induced, Loss of Glutamate Transporters and Spatial Memory

   • Holly M. Brothers
   • Isabelle Bardou
   • Gary L. Wenk

   BRIEF REPORT 25 May 2013 Pages: 1098 - 1105

   

9. Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients

   • Laura D. Serpero
   • Gilberto Filaci
   • Daniela Fenoglio

   BRIEF REPORT Open access 07 May 2013 Pages: 1106 - 1113

   

10. Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale

    • Sara Cross
    • Nur Önen
    • Beau M. Ances

    BRIEF REPORT 10 October 2013 Pages: 1114 - 1122

11. A Concise Panel of Biomarkers Identifies Neurocognitive Functioning Changes in HIV-Infected Individuals

    • Thomas D. Marcotte
    • Reena Deutsch
    • for the CHARTER Group

    INVITED REVIEW 08 October 2013 Pages: 1123 - 1135

    

12. A Biological Perspective of CSF Lipids as Surrogate Markers for Cognitive Status in HIV

    • Norman J. Haughey
    • Xiaomao Zhu
    • Veera Venkata Ratnam Bandaru

    INVITED REVIEW 08 November 2013 Pages: 1136 - 1146

    

13. Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection

    • Richard W. Price
    • Julia Peterson
    • Magnus Gisslen

    INVITED REVIEW Open access 13 August 2013 Pages: 1147 - 1158

    

14. Protease Resistant Protein Cellular Isoform (PrP^c) as a Biomarker: Clues into the Pathogenesis of HAND

    • Bezawit Megra
    • Eliseo Eugenin
    • Joan W. Berman

    INVITED REVIEW 25 April 2013 Pages: 1159 - 1166

    

15. Oxidative Stress and the HIV-Infected Brain Proteome

    • Lerna Uzasci
    • Avindra Nath
    • Robert Cotter

    INVITED REVIEW 09 March 2013 Pages: 1167 - 1180

    

16. Epigenetics, Drugs of Abuse, and the Retroviral Promoter

    • Jasmine Shirazi
    • Sonia Shah
    • Pooja Jain

    INVITED REVIEW 12 November 2013 Pages: 1181 - 1196

    

17. Alterations in the Levels of Vesicular Trafficking Proteins Involved in HIV Replication in the Brains and CSF of Patients with HIV-associated Neurocognitive Disorders

    • Jerel Fields
    • Wilmar Dumaop
    • Eliezer Masliah

    ORIGINAL ARTICLE 30 November 2013 Pages: 1197 - 1209

    

18. Modulation of BK Channel by MicroRNA-9 in Neurons After Exposure to HIV and Methamphetamine

    • Erick T. Tatro
    • Shannon Hefler
    • Cristian L. Achim

    ORIGINAL ARTICLE 19 March 2013 Pages: 1210 - 1223

    

19. Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection

    • Adrian A. Epstein
    • Prabagaran Narayanasamy
    • Michael D. Boska

    ORIGINAL ARTICLE Open access 24 May 2013 Pages: 1224 - 1238

    

20. Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction

    • Rebecca Hartzell Robinson
    • Joseph J. Meissler
    • Toby K. Eisenstein

    ORIGINAL ARTICLE 04 July 2013 Pages: 1239 - 1250

    

21. Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund’s Adjuvant in Three Non-human Primate Species

    • Krista G. Haanstra
    • S. Anwar Jagessar
    • Bert A. ’t Hart

    ORIGINAL ARTICLE Open access 03 July 2013 Pages: 1251 - 1264

    

22. Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype

    • Ewa Kozela
    • Ana Juknat
    • Zvi Vogel

    ORIGINAL ARTICLE 28 July 2013 Pages: 1265 - 1276

    

23. Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab

    • Maria Inmaculada Dominguez-Mozo
    • Marta Garcia-Montojo
    • Roberto Alvarez-Lafuente

    ORIGINAL ARTICLE 25 August 2013 Pages: 1277 - 1286

    

24. Identification of Novel MicroRNA Signatures Linked to Experimental Autoimmune Myasthenia Gravis Pathogenesis: Down-Regulated miR-145 Promotes Pathogenetic Th17 Cell Response

    • Jiao Wang
    • Shuangshuang Zheng
    • Yong Zhang

    ORIGINAL ARTICLE 17 September 2013 Pages: 1287 - 1302

    

25. Clonal Immortalized Human Glial Cell Lines Support Varying Levels of JC Virus Infection due to Differences in Cellular Gene Expression

    • Michael W. Ferenczy
    • Kory R. Johnson
    • Eugene O. Major

    ORIGINAL ARTICLE 20 September 2013 Pages: 1303 - 1319